English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
About ICMLF
Donate in John's memory
A special thank you to those who have already donated to the John Goldman fund. It's thanks to your contribution that the John Goldman fund comes to life supporting young physicians from the emerging regions.
To donate to the iCMLf John Goldman fund click here
Dr Adeagbo Babatunde, PhD
(Ile-Ife, Nigeria)
'It was an honour for me to present my data at this well-known conference on CML and to discuss the results with the international CML community. It was also a great chance for me to network with people from around the world and a great experience for me to listen to some of the most renowned leaders in the field of CML during the scientific sessions at the meeting.'
(Dr Babatunde, Nigeria)
Dr Babatunde was supported by the John Goldman Fund in 2015 to attend the John Goldman Conference on CML in Estoril. He presented his poster on ‘Pharmacokinetics on imatinib in Nigerians’ with CML during the interactive poster walks on the biology of CML.
Dr Carolina Pavlovsky, MD
Fundaleu Hospital and Clinical Research Center
Buenos Aires, Argentina
Carolina Pavlovsky works as a hematologist at Fundaleu (Foundation to fight Leukemia) in Buenos Aires and serves as Head of the Research Department since 2010. She received her doctorate from the University of Buenos Aires and completed her training in internal medicine and hematology at the National Academy of Medicine in Buenos Aires.
Her main interests are chronic leukemias: molecular and clinical aspects. Since 2003, she has worked on multiple research protocols for chronic leukemias and is in charge of CML and CLL projects. Since 2005, she has coordinated an Argentine multi-center study on molecular monitoring in patients with CML and since 2011 she coordinates the clinical aspects of a new multi-centric study on mutational analysis of patients with CML and treatment failure. In June 2008, she undertook a training at the Department of Leukemias at the MD Anderson Cancer Center in Houston. In 2014 she obtained a Master's degree in Molecular Oncology from the National Cancer Research Center of Spain (CNIO) and the European School of Oncology (ESO).
The iCMLf Partners
The iCMLf is pleased and proud to work with the following organisations to improve outcomes for people with CML around the world.
iCMLf website: A global community for CML researchers, clinicians and carers
"How did we ever do this before we had the Internet?” springs to mind when looking at international networks like the iCMLf, the European Leukemia Net or the CML Advocates Network. The Internet has become indispensable to share knowledge, collaborate and communicate globally. Despite CML being a rare disease, experts on all continents collaborate very closely to improve CML treatment. This worldwide community of hematologists is a perfect example for the Internet era. The iCMLf website aims to strengthen that community collaboration further.
